Aim: To produce a set of clinical indicators for cancer health care institutional providers to use as quality measures in the Clinical Indicator Program, a data collection and reporting service of ACHS that measures and benchmarks performance of aspects of clinical care in peer organisations, in addition to the existing ACHS Radiation Oncology clinical indicators.
Method: The Performance and Outcomes Service at ACHS coordinated a four‐stage process based on a modified Delphi approach. In Stage 1, the 16‐member Steering Committee scoped the broad parameters. Stage 2 consisted of a literature review and search of international benchmarks, then a ranking process based on ease of accessibility and clinical relevance. The broader stakeholder group met in Stage 3 to discuss the top ranked indicators and produce a final set. Finally, indicators were mapped to clinical codes and explained in a formal user manual, then ratified by COSA and the ACHS Board.
Results: The initial face to face meeting resolved the ‘big picture’ nature of the desired set and achieved consensus between Steering Committee members, comprising broad cancer craft group representation plus consumer representation. From an initial set of 65 potential indicators, ranking produced a list of 27 indicators which were discussed in detail with the broader stakeholder group (n=21) at a second face‐to‐face meeting. The final set of 16 cancer clinical indicators (Table 1) was ratified by COSA and ACHS for use in July 2020.
Conclusions: Despite initial concerns about generating a comprehensive set of cancer clinical indicators that covered the wide spectrum of cancer care, the structured expert consensus process worked smoothly to resolve a final set of 16 indicators that are considered easy to collect and clinically informative.